Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and papaverine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with papaverine in 4 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(papaverine)		Trials
(papaverine)		Recent Studies (post-2010) (papaverine)
9,1561875526,027305355

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)papaverine (IC50)
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10ARattus norvegicus (Norway rat)0.076
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)2.3
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)8.8
3',5'-cyclic-AMP phosphodiesterase Sus scrofa (pig)1.7
Bile salt export pumpHomo sapiens (human)10
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)1.6
Cytochrome P450 2C19Homo sapiens (human)0.762
Serine hydroxymethyltransferase, mitochondrialHomo sapiens (human)2.6915
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1AHomo sapiens (human)9
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BHomo sapiens (human)9
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)1.4
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)7.2444
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)1.03
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CHomo sapiens (human)9
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)0.697
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus (Norway rat)0.036
Phosphodiesterase Sus scrofa (pig)0.62
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10AHomo sapiens (human)0.07

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheung, LY; Wood, JG; Yan, ZY1
Fortes, ZB; Garcia-Leme, J; Scivoletto, R1
Esumi, N; Hashida, T; Imashuku, S; Nakajima, F; Todo, S; Tsunamoto, K1
Amico-Roxas, M; Caruso, A; Cutuli, VM; de Bernardis, E; Leonardi, G1

Other Studies

4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and papaverine

ArticleYear
Gastric microvascular actions of platelet-activating factor: role of leukocytes.
    The American journal of physiology, 1992, Volume: 262, Issue:3 Pt 1

    Topics: Analysis of Variance; Animals; Dogs; Dose-Response Relationship, Drug; Kinetics; Leukocytes; Male; Microcirculation; Muscle, Smooth, Vascular; Norepinephrine; Papaverine; Platelet Activating Factor; Regional Blood Flow; Stomach; Vascular Resistance

1992
Functional changes in the microcirculation of alloxan-induced diabetic rats.
    General pharmacology, 1989, Volume: 20, Issue:5

    Topics: Acetylcholine; Animals; Arterioles; Diabetes Mellitus, Experimental; Histamine; Male; Microcirculation; Norepinephrine; Papaverine; Platelet Activating Factor; Rats; Rats, Inbred Strains; Splanchnic Circulation; Tyramine; Vasoconstriction; Venules

1989
Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma.
    Progress in clinical and biological research, 1985, Volume: 175

    Topics: Abdominal Neoplasms; Alprostadil; Animals; Blood Coagulation Factors; Cell Differentiation; Cell Division; Cells, Cultured; Child; Child, Preschool; Cyclic AMP; Drug Evaluation; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Humans; Male; Mice; Neuroblastoma; Papaverine; Platelet Activating Factor; Prostaglandin D2; Prostaglandins D; Prostaglandins E

1985
Protective effects of papaverine salicylate in mouse ear dermatitis and PAF-induced rat paw oedema.
    Agents and actions, 1994, Volume: 42, Issue:1-2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cantharidin; Croton Oil; Dermatitis; Dose-Response Relationship, Drug; Ear, External; Edema; Male; Mice; Papaverine; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Zymosan

1994